Classification and diagnosis of female sexual disorders

2005 ◽  
pp. 323-330 ◽  
Author(s):  
Sandra Leiblum
2017 ◽  
Vol 89 (1) ◽  
pp. 7 ◽  
Author(s):  
Chiara Borghi ◽  
Lucio Dell'Atti

Female Sexual Disorders (FSD) include a complex, multidimensional, individual experience that can change as an individual age, suggesting that these problems are caused by multiple factors including psychosocial factors, personal relationships, pathologic changes caused by diseases, and pharmacologic influences. Menopause is an important time for middle aged women and postmenopausal physiological changes could have a significant role in the development of FSD. Few is still known about their correct definition and treatment. Their incidence, prevalence and risk factors are difficult to define because of a high level of overlap in the experience of problems with desire, arousal, and orgasm. Little evidences are known about the best therapeutic approach, and both non-pharmacological and pharmacological treatment options have been described. Among these, phosphodiesterase type 5 inhibitors could be an effective option for many subtypes of female sexual disorders, with an improvement in different aspects of sexual function, such as desire, arousal, orgasm and sexual satisfaction. In this paper authors reviewed what is already known about the use of these vasoactive agents, particularly tadalafil, as a treatment option for female sexual disturbances.


2018 ◽  
pp. 135-153
Author(s):  
Stephen J. Betchen ◽  
Heather L. Davidson

2002 ◽  
Vol 20 (2) ◽  
pp. 74-78 ◽  
Author(s):  
Aristotelis Anastasiadis ◽  
Anne Davis ◽  
Mohamed Ghafar ◽  
Martin Burchardt ◽  
Ridwan Shabsigh

CNS Spectrums ◽  
2011 ◽  
Vol 16 (2) ◽  
pp. 49-62 ◽  
Author(s):  
Sheryl A. Kingsberg ◽  
Gail Knudson

AbstractSexual health is important to overall health and quality of life. Sexual problems have been associated with relationship problems and may interfere with overall health and they may also be a marker for other undiagnosed comorbid medical conditions. In order for healthcare professionals to manage the sexual health concerns of their patients, it is important for them to understand what constitutes good sexual health. To that end, it is necessary to have a working knowledge of the evolving theoretical models offered to describe a healthy sexual response as well as an understanding of the neurobiology of sexual function. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Revised lists six primary female sexual disorders: hypoactive sexual desire disorder, sexual aversion disorder, female sexual arousal disorder, female orgasmic disorder,dyspareunia, and vaginismus. Despite a growing awareness of the high prevalence of sexual disorders they are not typically identified nor treated. There are a number of reasons why clinicians fail to identify and treat sexual problems including insufficient training in sexual medicine and communication skills, time-constraints, and embarrassment. Treatment for female sexual problems is usually individualized and may include a combination of office-based education and basic counseling, cognitive-behavioral psychotherapy, pharmacotherapy, and treatment of concomitant medical conditions.


Sign in / Sign up

Export Citation Format

Share Document